Stay updated on Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial
Sign up to get notified when there's something new on the Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial page.

Latest updates to the Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial page
- Check6 days agoChange DetectedRecruitment is now shown as closed to participants, and the history includes a new Revision: v3.6.0 while removing Revision: v3.5.5.SummaryDifference0.6%

- Check13 days agoChange DetectedVersion 6 updates the study record with revisions to core sections (Study Status, Recruitment Status, Eligibility, Arms and Interventions, Conditions, Study Description) and adds new sections (Outcome Measures), labeled v3.5.5 on 2026-05-28 (with related changes on 2026-05-27). The previous status (Active, not recruiting) was removed and the prior revision (v3.5.4) is replaced.SummaryDifference2%

- Check21 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision entry, Revision: v3.5.4, is added to the Record History page, and the previous Revision: v3.5.3 entry is removed. This updates the page's historical record to reflect the latest release.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s displayed software/version indicator for the ClinicalTrials.gov site was updated to a newer release (v3.5.3). This corresponds to a site maintenance/update rather than a change to the trial record itself.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision v3.5.2 was added to the Record History and revision v3.5.0 was removed.SummaryDifference0.1%

- Check92 days agoChange DetectedA new version entry (v3.5.0) was added and an older version (v3.4.3) was removed from the record history.SummaryDifference0.1%

Stay in the know with updates to Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial page.